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Abstract
Evidence from several studies indicates the importance of Gaq protein-coupled receptor (GPCR) signaling pathway,
which includes diacylglycerol (DAG), and protein kinase C, in the development of heart failure. DAG kinase (DGK)
acts as an endogenous regulator of GPCR signaling pathway by catalyzing and regulating DAG. Expressions of DGK
isoforms a, ε, and ζ in rodent hearts have been detected; however, the expression and alteration of DGK isoforms
in a failing human heart has not yet been examined. In this study, we detected mRNA expressions of DGK isoforms
g, h, ε, and ζ in failing human heart samples obtained from patients undergoing cardiovascular surgery with
cardiopulmonary bypass. Furthermore, we investigated modulation of DGK isoform expression in these hearts. We
found that expressions of DGKh and DGKζ were increased and decreased, respectively, whereas those of DGKg and
DGKε remained unchanged. This is the first report that describes the differential regulation of DGK isoforms in
normal and failing human hearts.
Introduction
Epidemiological studies have suggested that cardiac
hypertrophy is an independent risk factor for the devel-
opment of heart failure and is associated with increased
cardiac morbidity and mortality in patients with cardio-
vascular diseases [1-3]. Recent in vivo and inv i t r ostu-
dies have focused on protein kinase signaling cascades
as the molecular mechanisms regulating the hyper-
trophic response of cardiomyocytes [4,5]. Among these
signaling pathways, the Gaq protein-coupled receptor
(GPCR) signaling pathway, which includes diacylglycerol
(DAG) and protein kinase C (PKC), plays a critical role
in the development of cardiac hypertrophy and progres-
sion to heart failure (HF) [6-8].
The main route for termination of DAG signaling is
through phosphorylation by DAG kinase (DGK) to pro-
duce phosphatidic acid [9,10]. To date, at least 10 DGK
isoforms–DGKa, b, g, δ, ε, ζ, h, θ, ι,a n d– have been
identified in mammals; DGK isoforms have been
reported to be expressed in various tissues, suggesting
the importance of these kinases in basic cellular func-
tions [11,12]. In rodent hearts, the expressions of
DGKa, ε, and ζ isoforms have been detected, and differ-
ential regulation of DGK isozymes in the development
of pressure-overload cardiac hypertrophy and in left
ventricular remodeling after myocardial infarction has
been shown [13,14]. Evidence from several in vitro [15]
and in vivo [16] studies suggests that DGKζ blocks
GPCR-induced activation of PKC, and suppresses cardi-
omyocyte hypertrophy and progression of heart failure.
However, the expression of DGK isoforms in failing
human heart has not been previously examined. There-
fore, the purpose of this study was (1) to identify the
DGK isoforms in the right atrial myocardium in patients
undergoing cardiac surgery with cardiopulmonary
bypass and (2) to examine changes in expressions of
DGK isoforms in cases of failing human heart due to
chronic volume overload.
Materials and methods
Study patients and materials
Intraoperative samples of the right atrial myocardium
w e r eo b t a i n e df r o mat o t a lo f1 7p a t i e n t sw h ou n d e r -
went cardiac surgery at the Yamagata University Hospi-
tal between February 2006 and September 2007. All
procedures were performed in accordance with the ethi-
cal standards outlined in the Declaration of Helsinki of
1975 (revised 1983). The research protocol was
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written informed consent was obtained from all subjects.
Heart samples were obtained from 10 consecutive
patients [mean age: mean (SD), 63 (13) years; 7 men
and 3 women] admitted for surgical correction of
chronic regurgitation associated with mitral valvular
lesions (valvular replacement or valvuloplasty, n = 6) or
combined dual-valve replacement (n = 4) (Table 1).
Right atrial tissue samples collected from 7 patients with
aortic dissection, no structural cardiac diseases, and nor-
mal heart function were used as controls. Small samples
of the right atrium tissue were collected when patients
underwent median sternotomy with aortic and right
atrial cannulation. The samples were obtained in the
operating room and rapidly frozen in liquid nitrogen
until further use.
RNA preparation and reverse transcription-polymerase
chain reaction analysis
Extraction of DNA-free total cardiac RNA was per-
formed using the RNeasy fibrous tissue mini kit (Qia-
gen, Tokyo, Japan) according to the manufacturer’s
instructions. For conventional reverse transcriptase poly-
merase chain reaction (RT-PCR) analysis, 1 μgo ft o t a l
RNA was reverse-transcribed using the QuantiTect
reverse transcription kit (Qiagen) [17,18]. The primer
pairs for human DGK isoforms used for PCR analysis
were designed on the basis of GenBank sequences
(DGKa, BC031870; DGKb, AB018261; DGKg,
BM669549; DGKδ, BC006561; DGKε, U49379; DGKζ,
U94905; DGKh, AK098302; DGKθ, BC063801; DGKι,
AF061936; DGK, AB183864; GAPDH, M33197). PCR
products were characterized by performing agarose gel
electrophoresis on 2% Tris/borate/EDTA (TBE) agarose
gel and visualized by ethidium bromide staining. Densi-
tometry of the bands was performed using ImageJ
(v1.29s NIH). The intensities of the bands were normal-
ized for GAPDH. Each reaction included positive and
negative controls. Total RNA from Human brain
(Ambion, Cat. No. AM7962) and HeLa cells were used
as positive controls.
Statistical Analysis
Data are presented as mean (SD). Differences between
the 2 groups were evaluated using Student’s t test, and a
P-value of <0.05 was considered statistically significant.
All statistical analyses were performed with a standard
statistical program package (JMP version 8; SAS Insti-
tute Inc., Cary, North Carolina).
Results
Analysis of DGK isoform expression in a normal heart
First, we confirmed the expression of DGKa, b, g, ε, ζ,
h, θ,a n dι in human brain cells and that of DGKδ, ε,
ζ,a n dh in the HeLa cell line by using RT-PCR (data
not shown). The human brain or HeLa cells did not
show the expression of DGK. This finding is consis-
tent with that reported by a recent study that showed
t h ep r e s e n c eo fD G K  mRNA only in the human testis
and placenta tissues [19]. Therefore, we used mRNA
from the human brain and HeLa cells as positive con-
trol for further experiments using human heart tissue.
Clinical and hemodynamic characteristics of patients with
heart failure
Clinical characteristics and echocardiographic and
hemodynamic measurements of heart failure patients
undergoing valvular replacement or valvuloplasty are
shown in Table 1. Five patients showed New York
Heart Association (NYHA) functional class III heart
failure, and another 5 patients showed class IV heart
failure. Echocardiography revealed that the patients
had marked left ventricular dilatation (LVDD, 64 (7)
mm vs. 47 (4) mm in control, P < 0.0001) and left
atrium dilatation (LAD, 56 (13) mm vs. 35 (6) mm in
control, P = 0.0011). Six patients had atrial fibrillation.
Five patients had low cardiac index (<2.5 L/min/m
2.
Elevation of pulmonary arterial pressure (PAP systolic
≥30 mmHg), pulmonary capillary wedge pressure
(mean of PCWP ≥12 mmHg), and right ventricular
pressure (RVP systolic ≥30 mmHg) was observed in 7,
6, and 8 patients, respectively. Echocardiography
revealed moderate to severe tricuspid regurgitation in
4 patients. A large proportion of patients had right
atrial overload.
The expression of the DGK isoforms in the human
right atrium was examined in the control heart speci-
mens by using RT-PCR. RT-PCR analysis performed
using oligonucleotide primers specific for the 10
human DGK isoforms revealed 4 DGK isoforms DGKg,
DGKh,D G K ε,a n dD G K ζ in normal human hearts
(Figure 1).
Changes in DGK isoform expression in hearts with
volume-overload
To investigate the changes in mRNA levels of the DGK
isoforms in patients with volume-overloaded atria, we
examined the expression levels of DGKg,D G K h,D G K ε,
and DGKζ isoforms in the right atrium specimens
obtained from heart failure patients and compared them
with the corresponding expression levels in the control
heart samples. Volume overload caused changes in the
expression levels of DGKh and DGKζ. Expression level
of DGKh was significantly increased (Figure 2A), while
that of DGKζ was significantly decreased (Figure 2B). In
contrast, expression levels of DGKg and DGKε remained
unchanged in the patients with chronic overload in the
right atrium.
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All DGK family members share conserved domains and
are subdivided into 5 functional classes on the basis of
t h es u b t y p e - s p e c i f i cr e g u l a t o r yd o m a i n s[ 1 2 ] .D G K
represents a large family of isoforms that differ remark-
ably in their structure, tissue expression, and enzymatic
properties, and are encoded by different genes [11];
however, to the best of our knowledge, DGK isoform
expression in the human heart has not been previously
examined.
In the present study, we used the right atrium tissue
to determine the expression of DGK isoforms. Chronic
mitral regurgitation is a state of volume overload that
causes complex hemodynamic changes [20-22]. Chronic
mitral insufficiency leads to the enlargement of the left
atrium, pulmonary congestion, and failure of the right
heart. Pulmonary hypertension occurs frequently (in
76% of cases) in patients with isolated chronic mitral
regurgitation with preserved left ventricular systolic
function [23]. Samples of the left ventricular myocar-
dium obtained from patients who were undergoing
orthotopic cardiac transplantation have been used in
several studies, thereby suggesting that the hearts were
in the state of end-stage in most cases, and were modi-
fied by endogenous and exogenous stimuli [24,25]. In
the light of these facts, in this study, the right atrium
samples were obtained from patients with chronically
stressed hearts; these samples were suitable for deter-
mining the clinical significance of DGK in modulation
of progressive heart failure.
We detected 4 DGK isoforms belonging to 4 different
classes in the human heart. Unlike DGKa expression in
control MR control MR A B
DGKȗ DGKȘ
GAPDH GAPDH
s
s
i
o
n P<0.0001
2.0
s
i
o
n P=0.002
1.6
v
e
 
e
x
p
r
e
s
o
f
 
 
D
G
K
ȗ
e
 
e
x
p
r
e
s
s
f
 
 
D
G
K
Ș
R
e
l
a
t
i
v
o
0
R
e
l
a
t
i
v
o
f
0
controlM R
0
control MR
Figure 2 Diacylglycerol kinase (DGK)h (A) and DGKζ (B) mRNA expressions in right atrial samples obtained from patients with and
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Figure 1 Expressions of diacylglycerol kinase (DGK) isoforms in normal human right atrium.
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expressed in the human heart, thereby implying that
DGKa in the rodent model can be applied as a molecu-
lar target for confirming the clinical significance of
DGKg in the human heart. Although no changes were
detected in the expression level of DGKg in failing
h e a r t ,w es u s p e c t e dt h a tD G K g might be activated and
might contribute to the process of progressive heart fail-
ure. Since the class I DGKs are characterized by the pre-
sence of an EF hand motif (a Ca
2+-binding domain) [26],
Ca
2+ overload, which is one of the key features of a fail-
ing heart and which induces mitochondrial disorganiza-
tion and cardiomyocyte apoptosis [27], might modulate
the activity of class I DGKs in failing hearts.
We identified the expression of DGKh in the human
right atrium but could not detect it in rodent hearts
[14,28]. Although its functional role is not yet clear, it is
noteworthy that the expression of DGKh was increased
in the failing hearts affected by volume overload.
Recently, Yasuda et al. have reported that DGKh acti-
vates Ras/B-Raf/C-Raf/MEK/ERK signaling pathway by
regulating B-Raf-C-Raf heterodimer formation [28],
thereby suggesting that increased DGKh expression
might affect the process of heart failure. Understanding
o ft h er o l eo fD G K h in human heart failure might be
valuable for determining a novel therapeutic target in
the future.
Downregulation of DGKε in rat hearts was observed
in both myocardial infarction and aortic banding models
[13,14]. In the present study, expression of DGKε was
unchanged in the failing human hearts. One possible
explanation for this discrepancy is that regulation of
DGK isoform expression might be different in different
species under different hemodynamic conditions.
In this study, atrial expression of DGKζ,w h i c h
belongs to class IV, was significantly decreased in the
human hearts affected by volume overload. On the
other hand, several contradictory findings have reported
in animal models of heart failure. In rat hearts affected
by chronic pressure overload, translocation of DGKζ
from nuclear to cytosolic cell fraction was indicated
[13]. DGKζ upregulation was reported in the peripheral
z o n eo ft h en e c r o t i ca r e ai ni n f a r c t e dr a th e a r t s[ 1 4 ] .
We have previously reported that DGKζ mRNA levels
in neonatal cardiomyocytes increased in the acute phase,
but immediately returned to basal levels after endothe-
lin-1 stimulation [15]. In this study, since the hearts
were under continuous strain for a long time due to
volume overload, DGKζ expression might be decreased
in failing human hearts. We have previously reported
the importance of DGKζ in abrogating the progress of
ventricular remodeling. DGKζ has been reported to inhi-
bit endothelin-1-induced PKCε translocation and hyper-
trophic responses in neonatal rat cardiomyocytes [15].
Cardiac-specific overexpression of DGKζ has been
reported to prevent angiotensin II- and phenylepinephr-
ine-induced activation of several PKCs and subsequent
cardiac hypertrophy [16]. Our findings may reflect a
pathophysiological importance of DGKζ in the regula-
tion of cardiac hypertrophy and heart failure in the
human heart. On the basis of these facts, we thought
that upregulation of DGKζ could be a therapeutic target
in patients with heart failure.
Conclusions
In conclusion, this study is the first to provide evidence
of differential regulation of human DGK isoforms in
failing human heart affected by volume overload,
thereby suggesting that individual DGK isoforms may
have unique properties, and consequently, distinct func-
tions in the regulation of cardiac hypertrophy and heart
failure.
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